Premium
Intravenous buscopan for analgesia following laparoscopic sterilisation
Author(s) -
Wilson C. M.,
Lillywhite N.,
Matta B.,
Mills P.,
Wiltshire S.
Publication year - 1999
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1046/j.1365-2044.1999.00858.x
Subject(s) - medicine , anesthesia , anticholinergic , analgesic , placebo , laparoscopy , saline , pelvic pain , muscle relaxant , general anaesthesia , surgery , alternative medicine , pathology
Following reports that tubal smooth muscle spasm may contribute to pelvic pain following laparoscopic sterilisation, we studied the effect of buscopan (an anticholinergic agent used to relieve smooth muscle spasm) on 45 patients undergoing general anaesthesia for day‐case laparoscopic sterilisation. Patients were randomly allocated to receive either buscopan 20 mg or saline placebo after induction of anaesthesia. There were no significant differences in pain scores or postoperative analgesic requirements between the two groups. We conclude that intravenous buscopan confers no benefit in day‐case laparoscopic sterilisation.